CLSN DEADLINE ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Celsion Corporation – CLSN

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Celsion Corporation (NASDAQ: CLSN) between November 2, 2015 and July 10, 2020, inclusive (the “Class Period”).

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=celsion-corporation&id=2458 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=celsion-corporation&id=2458

If you wish to serve as lead plaintiff, you must move the Court before the December 29, 2020 DEADLINE.   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. 

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:  defendants had significantly overstated the efficacy of ThermoDox; the foregoing significantly diminished the approval and commercialization prospects for ThermoDox; as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756



Richardson Electronics Strengthens Power Conversion Product Offering with Fuji Electric’s 7th Generation (X-Series) IGBT Modules

LA FOX, Ill., Nov. 19, 2020 (GLOBE NEWSWIRE) — Richardson Electronics, Ltd. (NASDAQ: RELL) strengthened their power conversion product offering with Fuji Electric’s 7th generation (X-Series) IGBT modules.

Fuji’s 7thGeneration IGBT modules represent the latest IGBT chip technology and is specifically designed to complement requirements needed for the latest power conversion applications including energy savings, miniaturization, and increased reliability. Key features are:

  • The module has been optimized by thinning the thickness and miniaturizing the structure of the IGBT chip and diode chip that makes up the module, reducing power loss when compared to previous generations. Applications have seen inverter loss reduced by 10% and chip temperature improved by 11°C.
  • A newly developed insulating board has improved the heat dissipation of the module, allowing a footprint reduction of 36% while reducing power loss and suppressing heat generation when compared with previous generations.
  • Higher temperature operation: This new series is rated for continuous operation at 175°C allowing up to 35% more output; doubling power cycling capabilities compared to previous generations.

Product series includes 650/1200/1700V, 10-1800A, offered in small PIM, EconoPIM™, 6-Pack, Dual, Dual XT, EconoPACK™ and PrimePACK™ packages

With over 90 years of experience, Fuji Electric is a leading developer of industrial products such as IGBT power modules, intelligent power modules, discrete rectifier diodes, and discrete MOSFET & IGBT devices.

“Fuji Electric’s X-Series comes in a wide array of package types and voltage ranges making it ideal for our customers,” said Greg Peloquin, Executive Vice President of Richardson Electronics’ Power & Microwave Technologies group “The X-Series features and benefits coupled with our team’s expertise – I am confident we will be able to deliver a best-in-class solution.”

“Our 7th Generation X-Series IGBT Technology combined with the excellent support from Richardson Electronics’ Power & Microwave Technologies group provides our valued customers with the highest level of commercial and technical support,” said James Usack, Division General Manager, Fuji Electric America

PrimePACK™ is registered trademark of Infineon Technologies AG, Germany. EconoPIM™ is registered trademark of Infineon Technologies AG, Germany. EconoPACK™ is registered trademark of Infineon Technologies AG, Germany


About Richardson Electronics, Ltd.

Richardson Electronics, Ltd. is a leading global provider of engineered solutions, power grid and microwave tubes and related consumables; power conversion and RF and microwave components; flat panel detector solutions and replacement parts for diagnostic imaging equipment; and customized display solutions. We serve customers in the alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The Company’s strategy is to provide specialized technical expertise and “engineered solutions” based on our core engineering and manufacturing capabilities. The Company provides solutions and adds value through design-in support, systems integration, prototype design and manufacturing, testing, logistics, and aftermarket technical service and repair through its global infrastructure. More information is available at www.rell.com.

Richardson Electronics common stock trades on the NASDAQ Global Select Market under the ticker symbol RELL.


About Richardson Electronics – Power & Microwave Technologies

For 70 years, Richardson Electronics has been your industry-leading global provider of engineered solutions, RF & microwave, and power products. With the launch of the Power & Microwave Technologies group, we continue this legacy and complement it with new products from the world’s most innovative technology partners. Richardson Electronics’ Power & Microwave Technologies group focuses on what we do best: identify and design disruptive technologies, introduce new products on a global basis, develop solutions for our customers, and provide exceptional worldwide support. As a global company, we provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics, and aftermarket technical service and repair—all through our existing global infrastructure. More information is available at www.rellpower.com.

For Details Contact:
                           

Chris Marshall
CTO/VP of Marketing                                       
Phone: (630) 208-2222                          
[email protected]



Couchbase Honored with Two Industry Awards: Battery Ventures’ Top 25 Cloud-Computing Companies to Work For and Deloitte’s Top 500 Fastest-Growing Companies in North America

Leading NoSQL database provider recognized on Battery Ventures’ list of top private cloud-computing companies to work for, and for the fourth consecutive year, the Deloitte Technology Fast 500™

Santa Clara, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) — Couchbase, the creator of the enterprise-class, multicloud to edge NoSQL database, today announced it has been named to Battery Ventures’ list of the 25 Highest-Rated Private Cloud Computing Companies to Work for During the COVID Crisis. The ranking is based on Couchbase’s Glassdoor reviews over the past six months, which demonstrates the company’s ability to lead during a crisis. And for the fourth consecutive year, Couchbase also announced it has been named to the Deloitte Technology Fast 500TM, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, and energy tech companies in North America. 

This year’s Top Privately-Held Cloud-Computing Companies to Work For list is a twist on Battery’s annual list of highest-rated cloud firms in terms of employee happiness. The list is based on data collected during the first six months of the pandemic from jobs and recruiting site, Glassdoor, which measures employee satisfaction at work. Battery elected this year to focus on company ratings only during the pandemic, given the tremendous disruption COVID-19 has caused many companies. Couchbase’s inclusion on this list highlights the company’s ability to lead during a crisis. But more broadly, the rankings can be an indicator of corporate innovation, growth and strong financial performance.

“We are honored to be included on Battery’s list,” said Matt Cain, President and CEO of Couchbase.  “We are doing everything we can as a company to protect and help our employees and their families, along with our customers and partners, as we collectively navigate the challenges of this pandemic.  This recognition is really a testament to the character, dedication, and toughness of the extended Couchbase team and its unrelenting focus to do the right thing by those we serve.  We pride ourselves at Couchbase not only on what we do, but how we do it, and current circumstances are no exception.”

Couchbase’s inclusion in the Deloitte Technology Fast 500TM list, for the 4th consecutive year, recognizes the exceptionally high rate of growth achieved through a consistent focus on sustained differentiation and innovation in service of its customers.   New products launched over the past year include Couchbase Cloud, the fully-managed database as a service; Couchbase Server 6.6; Couchbase Sync Gateway and Couchbase Lite version 2.8; and Couchbase Autonomous Operator 2.0.  As a result, existing customers such as AppDynamics, AT&T, BD, Carrefour, and Zynga expanded their relationships and new logos including Bankinter, S.A, Evernote, Orange Espana and TripActions were added.  To support the continued expansion of the company, Couchbase grew its employee base substantially over the previous fiscal year. 

“We are becoming the next great enterprise software company by simultaneously delivering sustained differentiation, driving long-term profitable growth, and building a world-class team,” continued Cain. “We are proud to be named to the Deloitte Technology Fast500 for the 4th consecutive year as a result of our continued focus and commitment to all of these areas as we accelerate growth of our technical innovation, our customer base, and our talent.  I’d like to thank our customers, partners and employees for making all of this possible.”

The two latest industry awards add to a growing list of recognition that Couchbase has garnered this year, including:

About Battery Ventures

Battery strives to invest in cutting-edge, category-defining businesses in markets including software and services, Web infrastructure, consumer Internet, mobile and industrial technologies. Founded in 1983, the firm backs companies at stages ranging from seed to private equity and invests globally from offices in Boston, the San Francisco Bay Area, London, New York and Israel. Follow the firm on Twitter @BatteryVentures, visit our website at www.battery.com and find a full list of Battery’s portfolio companies here.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

About Couchbase

Unlike other NoSQL databases, Couchbase provides an enterprise-class, multicloud to edge database that offers the robust capabilities required for business-critical applications on a highly scalable and available platform. As a distributed cloud-native database, Couchbase runs in modern dynamic environments and on any cloud, either customer-managed or fully managed as-a-service. Couchbase is built on open standards, combining the best of NoSQL with the power and familiarity of SQL, to simplify the transition from mainframe and relational databases. 

Couchbase has become pervasive in our everyday lives; our customers include industry leaders Amadeus, American Express, Carrefour, Cisco, Comcast/Sky, Disney, eBay, LinkedIn, Marriott, Tesco, Tommy Hilfiger, United, Verizon, as well as hundreds of other household names. For more information, visit www.couchbase.com

© 2020 Couchbase, Inc.  All rights reserved.  Couchbase, the Couchbase logo, and the names and marks associated with Couchbase’s products are trademarks of Couchbase, Inc.  All other trademarks are the property of their respective owners. 

###



Christina Knittel
Couchbase
7752092461
[email protected]

PGEN, XON IMPORTANT DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon– PGEN, XON

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Precigen, Inc. f/k/a (NASDAQ: PGEN, XON) from May 10, 2017  through September 25, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Precigen, Inc. f/k/a Intrexon Corporation investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that adverse facts about its business. As such, the Company’s financial statements for the quarter ended March 31, 2018 were false and could not be relied upon; the Company had material weaknesses in its internal controls over financial reporting; the Company was under investigation by the SEC since October 2018; and as a result of the foregoing, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than December 4, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
——————————-

Contact:  
Vik Pawar, Esq.  
Pawar Law Group  
20 Vesey Street, Suite 1410  
New York, NY 10007  
Tel: (917) 261-2277  
Fax: (212) 571-0938  
[email protected] 



New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer Patients

— Study finds nearly 1 in 10 show genetic changes with established clinical management recommendations, potential eligibility for precision therapies and/or clinical treatment trials —

— Data presented at the National Society of Genetic Counselors Annual Conference, which will also include ceremony honoring excellence in genetic counseling patient care —

PR Newswire

SAN FRANCISCO, Nov. 19, 2020 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today presented study findings that show nine percent of patients with pancreatic cancer had genetic changes in DNA damage repair (DDR) genes that would make them eligible for PARP inhibitor therapy or clinical treatment trials. Despite professional guidelines that recommend testing for all pancreatic cancer patients, it remains underutilized in routine care. The study was presented at the National Society of Genetic Counselors 39th Annual Conference.

“New therapeutics have recently become available to treat pancreatic cancer for patients with certain changes in genes such as BRCA1 and BRCA2. Yet despite the availability of these treatments and professional guidelines recommending testing, utilization is still lagging,” said Robert Nussbaum, M.D., chief medical officer of Invitae and study author. “Pathogenic variants in these genes are associated with an increased risk of other cancers as well, such as breast, ovarian and prostate cancer, which means that a failure to test patients with pancreatic cancer impacts not only their treatment, but also the health of their families.”

Importantly, the study of over 2,000 patients found that 15% of patients with actionable genetic changes reported no family history of cancer, which underscores the limitations of using testing criteria based on reported family history.  National Comprehensive Cancer Network (NCCN) guidelines recommend genetic counseling and germline genetic testing for everyone diagnosed with pancreatic cancer as well as their first degree relatives — approximately 3.5 million individuals in the United States.

In addition to evaluating the clinical relevance of genetic testing results, the study offered sponsored, no-charge testing to patients to evaluate the role of cost as a barrier to testing. Researchers found a small but significant increase (2%) in testing among African-American patients compared to typical rates among patients using health insurance, suggesting reducing cost may increase access to testing among this population.

The research was presented at the virtual annual meeting of the National Society of Genetic Counselors. The full research presentation from Invitae included:

Oral platform presentations:

  • Increasing access for patients with pancreatic cancer to germline genetic testing: Clinical impacts across disease stage and ethnicity. Presented by Ed Esplin, MD, PhD, FACMG, FACP
  • Evaluating variant reclassification in reproductive carrier screening. Presented by Julia Wilkinson, MS, LCGC

Poster presentations:

  • Utility of adding phenotypic criteria refinement to ACMG guidelines. Presented by Lauren Frank, MS, CGC
  • Comprehensive germline multigene panels change clinical care and inform treatment strategies for breast cancer patients. Presented by Sarah Nielsen, MS, LCGC
  • Carrier screening for X-linked conditions is common practice. Presented by Dana Neitzel, MS, CGC

In addition to its scientific presence, Invitae will again partner with NSGC to present the Heart of Genetic Counseling award, which honors excellence in genetic counseling and patient care as recognized by patients. Nominations include stories from patients that highlight both the clinical and personal impact a genetic counselor had on their lives and the lives of their families. This year’s award will be presented during a virtual ceremony on Thursday, November 17th. The finalists include:

  • Rachelle Manookian, MS, LCGC, City of Hope in Duarte, CA, was nominated by a man who had been searching for answers about the origin of his cancer for more than 10 years. He hoped that any identified mutations would lead to a newly developed drug or clinical trial that could attack his cancer with precision. Manookian left no stone unturned and remained in touch until she found a clinical trial. Thanks to Manookian’s persistence, he finally got answers and learned that his sons did not carry the same increased genetic risk of prostate cancer.
  • Donna McDonald-McGinn, MS, LCGC, Children’s Hospital of Philadelphia in Philadelphia, was nominated by the mother of a son with a rare genetic condition called 22q11.2 deletion syndrome. McDonald-McGinn has been his care coordinator and navigator for 21 years, explaining and managing the care that he has needed through his life. Always acting as his advocate, McDonald-McGinn has been there for each of his 21 surgeries and is a staunch advocate for those with 22q11.2 deletion syndrome.
  • Gretchen MacCarrick, MS, CGC, Johns Hopkins Medicine in Baltimore, was nominated by a mother whose daughter has Loeys-Dietz syndrome (LDS), which was discovered in 2005. For nearly 12 years, MacCarrick has been by their side guiding them. She explains what tests are needed, what the results mean and navigates their daughter’s care during their regular visits to Baltimore, including a major heart surgery. Importantly, MacCarrick has even developed a strong relationship directly with the patient who is now 16 and getting more engaged in her care.

About Invitae

Invitae Corporation (NYSE: NVTA) is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae’s goal is to aggregate the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company’s website at invitae.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the implications of the company’s study results; and the importance and potential benefits of genetic testing for pancreatic cancer patients. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to:  the company’s history of losses; the company’s ability to compete; the company’s failure to manage growth effectively; the company’s need to scale its infrastructure in advance of demand for its tests and to increase demand for its tests; the company’s ability to use rapidly changing genetic data to interpret test results accurately and consistently; security breaches, loss of data and other disruptions; laws and regulations applicable to the company’s business; and the other risks set forth in the company’s filings with the Securities and Exchange Commission, including the risks set forth in the company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020. These forward-looking statements speak only as of the date hereof, and Invitae Corporation disclaims any obligation to update these forward-looking statements.

Contact:

Laura D’Angelo


[email protected]

(628) 213-3283

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/new-study-highlights-the-importance-of-genetic-testing-for-pancreatic-cancer-patients-301177392.html

SOURCE Invitae Corporation

Ryan Sitton Inspires Energy Industry’s Future Leaders in Series of Speaking Events

Pinnacle founder shares industry experience in hopes of inspiring next generation

HOUSTON, Nov. 19, 2020 (GLOBE NEWSWIRE) — Ryan Sitton, founder of Pinnacle, the world’s largest reliability data analytics company and author of debut book, “Crucial Decisions,” was recently featured as a guest lecturer to university students enrolled in top energy management programs across the country. Featured topics included his vast knowledge of data analytics and the energy industry including potential challenges, opportunities and transitions. Sitton, the youngest person honored as a distinguished engineering alumnus by Texas A&M University, will continue to educate students through a series of speaking events into February 2021 on how data is redefining the energy industry and why the secret to sustainability is reliability.

In late October, Sitton was invited to virtually speak with students enrolled in the University of Tulsa’s energy department to share his vast experience with business analytics and data systems, explaining how big data helps industry leaders make complex decisions, a topic widely discussed in his newly released book, “Crucial Decisions.”

Most recently, Sitton spoke to students at Rice University during the university’s annual energy finance summit, moderated by Rachel Adams-Heard of Bloomberg, to share how energy supply and demand may change both domestically and globally in the coming years. Sitton also shared the changes ahead in the energy industry and what navigating those opportunities, challenges and transitions may look like for those involved.

Sitton and the Pinnacle team are ardent about investing time and resources into early stage innovative companies in the reliability technology space. In October, Pinnacle announced the establishment of Pinnacle Ventures, a corporate venturing fund, and a commitment to invest $50 million into startups with impactful data-driven solutions.

“Innovation is at the core of Pinnacle’s values,” said Sitton. “While we continue to drive innovation internally, we also want to empower others within the energy industry to do the same in order to make the energy industry the most reliable it has ever been. Students are our future and we want to inspire and support them in as many ways as we can, whether that be sharing our knowledge and expertise through these series of talks or by supporting early stage innovation companies, we are committed to continuously supporting and improving the energy industry.”

On Nov. 30, Sitton will sit down with students at Texas A&M University for a virtual distinguished lecture in energy. On Feb. 2, 2021, Sitton will speak to students at the University of Texas as a guest of the university’s energy symposium series.

For more information on Ryan Sitton, please visit: https://ryansitton.com.

About Ryan Sitton:

Ryan Sitton is the founder of one of the world’s largest reliability data analytics companies. He consults international corporations on energy markets, holds a number of patents in system design, and has served as chief energy regulator for the state of Texas. He has spent the last decade developing and applying quantitative methods to ensure optimal reliability.

About Pinnacle:

Headquartered in Pasadena, Texas, Pinnacle is exclusively focused on helping industrial facilities in the oil and gas, chemical, mining, and water and wastewater industries better leverage their data to improve reliability performance, resulting in increased production, optimized reliability and maintenance spend, and improvement in process safety and environmental impact. Pinnacle is privately held, and has been consistently recognized for its growth by Inc. Magazine, the Houston Business Journal, and more. For more information, visit pinnaclereliability.com.

MEDIA CONTACT:
Grace Withers
[email protected]
(225) 610-7818

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/dd5db00e-9aeb-43b8-9ade-f1b767366dc8



NOV. 20 DEADLINE Pawar Law Group Announces a Securities Class Action Lawsuit Against Fluidigm Corporation– FLDM

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) from February 7, 2019 through November 5, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Fluidigm Corporation investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the case: defendants made false and/or misleading statements and/or failed to disclose that: Fluidigm was experiencing longer sales cycles; as a result, Fluidigm’s revenue was reasonably likely to decline; and as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you wish to serve as lead plaintiff, you must move the Court no later than November 20, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
——————————-

Contact:  
Vik Pawar, Esq.  
Pawar Law Group  
20 Vesey Street, Suite 1410  
New York, NY 10007  
Tel: (917) 261-2277  
Fax: (212) 571-0938  
[email protected]



Marijuana Company of America Reports hempSMART™ Product Sales and Financial Highlights for Q3 2020

ESCONDIDO, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) — MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce today its hempSMART™ product sales and other financial highlights for the third quarter and nine months ending September 30, 2020.

  • Total revenues of hempSMART™ products were $53,195 for the third quarter ended September 30, 2020 as compared to $229,371 for the third quarter ended September 30, 2019. This is despite setbacks in sales due to the COVID pandemic and changes to the Company’s marketing focus. The Company anticipates increases during the remainder of the year due to international expansion, additional financing the Company expects to receive in Q4 for product and marketing, and an expanded marketing model.
  • Operating expense for the three months ended September 30, 2020 decreased to $607,237 as compared to $763,151 for the three months ended September 30, 2019, representing a substantial 20.4% reduction in operating expenses. This resulted in an improvement to operating loss to $591,212 for the third quarter ended September 30, 2020 as compared to $624,623 for the third quarter ended September 30, 2019, representing a 5.3% improvement.
  • Net loss decreased materially to $1,872,271 for the three months ended September 30, 2020 compared to $6,226,622 for the three months ended September 30, 2019, representing a decrease of $4,354,351. This is a direct result of management drastically reducing expenses, increasing efficiency and changing management earlier this year.
  • Total year to date revenues of hempSMART™ products were $217,972 for the nine months ended September 30, 2020 as compared to $552,761 for the nine months ended September 30, 2019, representing a 60.6% decrease year-over-year.
  • International revenues represented 43.4% and 39.0% of total revenues for the nine months ended September 30, 2020 and 2019, respectively.
  • Operating expense for nine months ended September 30, 2020 decreased to $1,966,013 as compared to $3,231,298 for the same period in 2019, representing a 39.2% reduction in operating expenses. This resulted in an improvement to operating loss to $1,858,604 for the nine months ended September 30, 2020 as compared to $2,838,396 for the same period in 2019, representing a 34.5% improvement.
  • Net loss decreased substantially to $4,177,391 for the nine months ended September 30, 2020 compared to a net loss of $10,878,622 for the same period in 2019, a decrease of $6,701,231. This reduction in net loss is the result of management’s focus on reducing expenses and relying less on convertible debt financing.
  • Total assets increased to $2,013,287 as of September 30, 2020 from $1,143,722 as of December 31, 2019.
  • The Company’s total current liabilities decreased significantly to $7,681,505 as of September 30, 2020 as compared to $11,745,065 for the year ended December 31, 2019, representing a 35% reduction in debt. This is a result of the company settling convertible debt and reducing its operational expense.
  • The Company’s investment in Natural Plant Extract of California (NPE) experienced several positive changes during the second and third quarter. An investor acquired the property and a 40% interest in the business in Q2. This helped to settle some legacy debts and give favorable terms for the lease. In addition, NPE was able to sell its non-storefront retail delivery license for $650,000, giving NPE the sufficient funds to expand its marijuana distribution and manufacturing operations. Additionally, during Q3, NPE was able to substantially complete the construction of the manufacturing lab.
  • During the third quarter, the Company and Global Hemp Group (GHG) entered into a Settlement Agreement relating to the JV investment. GHG agreed to make a $200,000 payment with $125,000 paid before September 30, 2020, and $75,000 payable no later than November 15, 2020, and to issue GHG common stock to the Company equal in value to $185,000 as of the date of the Agreement, or September 28, 2020, subject to a non-dilutive protection provision. In exchange for the settlement consideration, the Company has agreed to relinquish its ownership interest in the joint venture.

COVID-19 significantly affected our revenues and gross profit for Q3 and for the nine months ended September 30, 2020. However, the Company will continue to market its products aggressively as it continues to a monumental paradigm shift in pivoting and changing its marketing focus to direct to consumer ecommerce.

Jesus Quintero, CEO and CFO of the Company stated “We were very pleased to see the drastic reduction in overhead this quarter without negatively impacting operations. This will help make MCOA a more lean operation with lower expenses so that we can better navigate the ever changing CBD market without being as dependable on convertible debt. We expect to see sustainable demand for our uniquely formulated hempSMART™ CBD product brand during the rest of 2020 and into 2021 as our new marketing strategies and platforms become more effective as the COVID-19 situation improves. Our goal is to expand our hempSMART brand in the United States as well as internationally in the European and Latin American marketplaces.”

Please review the Form 10Q filed with the Securities and Exchange Commission on November 16, 2020 for additional financial details.

About Marijuana Company of America, Inc.

MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our
hempSMART
Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:

[email protected]

888-777-4362

Corporate Communications Contact: 
Capvoice
New York, New York
www.NetworkNewsWire.com 
212.418.1217 Office 
[email protected]  



Western Copper and Gold Announces Upsize of Over-Night Marketed Public Offering

PR Newswire

VANCOUVER, BC, Nov. 19, 2020 /PRNewswire/ – Western Copper and Gold Corporation (“Western” or the “Company) (TSX: WRN) (NYSE American: WRN) is pleased to announce that in connection with its previously announced over-night marketed offering of common shares of the Company (the “Common Shares”), the Company and a syndicate of underwriters (the “Underwriters”) have agreed to increase the size of the previously announced financing. Pursuant to the amended terms, the Company has agreed to sell 17,242,000 Common Shares at a price of $1.45 per Common Share (the “Offering Price”) for gross proceeds of approximately $25.0 million (the “Offering”). The Company has granted the Underwriters an option (the “Over-Allotment Option”), exercisable in whole or in part, at the sole discretion of the Underwriters, for a period of 30 days from and including the closing of the Offering, to purchase up to an additional 2,586,300 Common Shares at the Offering Price. If the Over-Allotment Option is exercised in full, the total gross proceeds to the Company would be approximately $28.8 million.

The Company shall pay the Underwriters a cash commission equal to 5.0% of the gross proceeds of the Offering, including any proceeds received from the exercise of the Over-Allotment Option, if any, subject to a 2.5% cash commission being payable on sales to members of the president’s list (the “President’s List”), such President’s List not to exceed $12.0 million.

The Company intends to use the net proceeds from the sale of the Common Shares to fund its exploration, engineering and permitting activities and for general working capital purposes.

The Offering will be made by way of a prospectus supplement (the “Prospectus Supplement”) to the Company’s existing Canadian base shelf prospectus (the “Base Shelf Prospectus”) and related U.S. registration statement on Form F-10 (SEC File No. 333-241689) (the “Registration Statement”). The U.S. form of Base Shelf Prospectus is included in the Registration Statement. The Prospectus Supplement has been filed with the securities commissions in each of the provinces and territories of Canada, except Québec, and the United States Securities and Exchange Commission (the “SEC”). The Canadian Prospectus Supplement (together with the related Canadian Base Shelf Prospectus) is available on SEDAR at www.sedar.com. The United States Prospectus Supplement (together with U.S. Base Shelf Prospectus and the Registration Statement) will be available on the SEC’s website at www.sec.gov. Alternatively, the Canadian Prospectus Supplement (together with the related Canadian Base Shelf Prospectus) and the United States Prospectus Supplement (together with the related United States Base Shelf Prospectus and the Registration Statement) may be obtained, when available, upon request by contacting the Company or Cormark Securities Inc. Royal Bank Plaza, North Tower, Suite 1800, Bay Street, Toronto, Ontario M5J 2J2.

Closing is expected on or about November 24, 2020 and is subject to regulatory approval including that of the Toronto Stock Exchange and NYSE American.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, nor will there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. The securities being offered have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon by the accuracy or adequacy of the Prospectus Supplements, the Base Shelf Prospectuses or the Registration Statement.

ABOUT WESTERN COPPER AND GOLD CORPORATION

Western Copper and Gold Corporation is developing the Casino Project, Canada’s premier copper-gold mine in the Yukon Territory and one of the most economic greenfield copper-gold mining projects in the world. For more information, visit www.westerncopperandgold.com.

On behalf of the board,

“Paul West-Sells”

Dr. Paul West-Sells
President & CEO
Western Copper and Gold Corporation

Cautionary Disclaimer Regarding Forward-Looking Statements and Information

This news release contains certain forward-looking statements concerning the Offering and the use of proceeds therefrom, anticipated developments in Western’s operations in future periods and other matters that may occur in the future. Statements that are not historical fact are “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995 and “forward looking information” as that term is defined in National Instrument 51-102 (“NI 51-102”) of the Canadian Securities Administrators (collectively, “forward-looking statements”). Forward-looking statements are frequently, but not always, identified by words such as “expects”, “anticipates”, “believes”, “intends”, “estimates”, “potential”, “possible” and similar expressions, or statements that events, conditions or results “will”, “may”, “could” or “should” occur or be achieved. These forward-looking statements may include, but are not limited to, statements regarding the Offering; the anticipated closing of the Offering; potential exercise by the Underwriters of their over-allotment option; the anticipated use of proceeds and other future plans; or other statements that are not statement of fact. In making the forward-looking statements herein, the Company has applied certain material assumptions including, but not limited to, the assumptions that all regulatory approvals of the Offering will be obtained in a timely manner; all conditions precedent to completion of the Offering will be satisfied in a timely manner; the Company will be able to raise additional capital as necessary; the circumstances surrounding the COVID-19 pandemic, although evolving, will stabilize or at least not worsen; that the extent to which COVID-19 may impact the Company, including without limitation disruptions to the mobility of Company personnel, increased labour and transportation costs, and other related impacts, will not change in a materially adverse manner; that all regulatory approvals required to complete the Company’s planned exploration and development activities will be received in a timely manner and on acceptable terms; that the Company is able to procure personnel, equipment and supplies required for its exploration and development activities in sufficient quantities and on a timely basis; and that general business conditions will not change in a materially adverse manner.

Forward-looking statements are statements about the future and are inherently uncertain, and actual results, performance or achievements of Western and its subsidiaries may differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements due to a variety of risks, uncertainties and other factors. Such risks and other factors include, among others, risks involved in fluctuations in gold, copper and other commodity prices and currency exchange rates; COVID-19 risks to employee health and safety and a slowdown or temporary suspension of operations in geographic locations impacted by an outbreak; uncertainties related to raising sufficient financing in a timely manner and on acceptable terms; and other risks and uncertainties disclosed in Western’s AIF and Form 40-F, and other information released by Western and filed with the applicable regulatory agencies.

Western’s forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made, and Western does not assume, and expressly disclaims, any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as otherwise required by applicable securities legislation. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.

Cision View original content:http://www.prnewswire.com/news-releases/western-copper-and-gold-announces-upsize-of-over-night-marketed-public-offering-301177384.html

SOURCE Western Copper and Gold Corporation

ALERT: NOV. 20 DEADLINE Pawar Law Group Announces a Securities Class Action Lawsuit Against GoHealth, Inc. – GOCO

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of GoHealth, Inc. (NASDAQ: GOCO) pursuant and/or traceable to the registration statement issued in connection with the Company’s July 2020 initial public offering (the “IPO”). The lawsuit seeks to recover damages for GoHealth, Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the Medicare insurance industry was undergoing a period of elevated churn, which had begun in the first half of 2020; (2) GoHealth suffered from a higher risk of customer churn as a result of its unique business model and limited carrier base; (3) GoHealth suffered from degradations in customer persistency and retention as a result of elevated industry churn, vulnerabilities that arose from the Company’s concentrated carrier business model, and GoHealth’s efforts to expand into new geographies, develop new carrier partnerships and worsening product mix; (4) GoHealth had entered into materially less favorable revenue sharing arrangements with its external sales agents; and (5) these adverse financial and operational trends were internally projected by GoHealth to continue and worsen following the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than November 20, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
——————————-

Contact:  
Vik Pawar, Esq.  
Pawar Law Group  
20 Vesey Street, Suite 1410  
New York, NY 10007  
Tel: (917) 261-2277  
Fax: (212) 571-0938  
[email protected]